Cervical cancer screening among US women with pelvic organ prolapse
This cross-sectional study of over 2.2 million US women reveals that while those with pelvic organ prolapse undergo cervical cancer screening at higher rates than women without the condition, screening coverage for women aged 50 and older with prolapse remains below Healthy People 2030 goals.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Every woman between the ages of twenty-one and sixty-five is encouraged to visit a doctor for a specific check-up designed to find early signs of cervical cancer. This screening is a powerful tool that catches problems before they become dangerous, yet for decades, the number of women who actually get these tests has remained stubbornly flat. While the goal is to have nearly eighty percent of eligible women screened, the current reality falls short, particularly for those over fifty, who face the highest risk of developing the disease. At the same time, many women experience a condition called pelvic organ prolapse, where the muscles and tissues supporting the pelvic organs weaken, allowing organs like the bladder or uterus to slip downward. This condition typically appears in women around the age of fifty-five, an age that overlaps significantly with the peak years for cervical cancer risk. Because these two health issues often exist in the same group of people, researchers wanted to know if the presence of prolapse changes how likely a woman is to get her cancer screening.
A team of researchers at the University of Michigan and the University of Illinois Chicago set out to answer this question by looking at a massive collection of health records from across the United States. They examined data from over two million women who were eligible for cervical cancer screening between 2017 and 2022. To ensure their findings were accurate, they carefully removed any women who had already had a hysterectomy or a history of gynecologic cancer, focusing only on those who still had a cervix and needed the test. They used computer codes from medical records to identify which women had been diagnosed with pelvic organ prolapse and which had not. By comparing these two groups, they could see if the presence of prolapse influenced whether a woman received her screening.
The researchers found that women with pelvic organ prolapse were indeed different from those without it. They tended to be older, with the majority falling between the ages of fifty and sixty-five, whereas women without the condition were generally younger. The group with prolapse also included a higher proportion of White women and a lower proportion of women with a college education compared to the group without prolapse. Despite these differences in age, race, and education, the women with prolapse were actually more likely to have received their cervical cancer screening. About seventy-three percent of women with prolapse had been screened, compared to just over seventy percent of women without the condition. This difference held true even after the researchers accounted for age, race, ethnicity, and education levels, suggesting that having prolapse itself is linked to a higher chance of getting screened.
When the researchers looked closer at specific groups, they found that women with prolapse were more likely to be screened across almost every category, including different races and education levels. For instance, White, Black, Asian, and Hispanic women with prolapse all had higher screening rates than their counterparts without prolapse. However, a significant gap remained for the oldest women. Even among those with prolapse, the screening rate for women aged fifty and older was still below the national health goals. This is a critical finding because this age group faces the highest risk for cervical cancer. While having a college education was associated with higher screening rates for everyone, it was not enough to bring the rates for older women up to the desired target.
The study concludes that while women with pelvic organ prolapse are currently getting screened at higher rates than those without, the system is still failing to reach enough of the older women who need it most. The fact that these women are more likely to be screened suggests that the medical visits they make to manage their prolapse might be creating opportunities for doctors to catch cervical cancer early. Yet, for women over fifty, these opportunities are not being fully utilized. The researchers emphasize that despite the progress seen in younger women and those with higher education, targeted strategies are still needed to ensure that the oldest and most vulnerable women receive the life-saving screening they require.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.